Erica A Eugster Selected Research

Precocious Puberty

1/2022	Gonadotropin-Releasing Hormone Analogs for Treatment of Central Precocious Puberty in Children Younger than 2 Years of Age.
10/2020	Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty.
1/2020	A Comparison of Patients with Central Precocious Puberty Who Have a Pubertal versus Prepubertal Ultrasensitive LH at Presentation.
5/2019	Treatment of Central Precocious Puberty.
1/2019	Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes.
1/2019	Update on central precocious puberty: from etiologies to outcomes.
1/2019	TESTOTOXICOSIS WITH AN EPISODIC COURSE: AN UNUSUAL CASE WITHIN A SERIES.
1/2018	Central precocious puberty: From genetics to treatment.
1/2017	One-Year Follow-Up of Girls with Precocious Puberty and Their Mothers: Do Psychological Assessments Change over Time or with Treatment?
1/2016	Treatment of Peripheral Precocious Puberty.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erica A Eugster Research Topics

Disease

33	Precocious Puberty 01/2022 - 07/2003
7	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 01/2016 - 07/2003
6	Turner Syndrome (Turner's Syndrome) 01/2021 - 12/2006
5	Neoplasms (Cancer) 01/2022 - 11/2003
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2011 - 06/2004
4	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2022 - 01/2004
4	Disease Progression 01/2019 - 12/2006
4	Hypothyroidism 06/2015 - 07/2002
4	Uterine Hemorrhage (Uterine Bleeding) 09/2012 - 07/2003
3	Graves Disease (Basedow Disease) 03/2009 - 07/2002
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 12/2021 - 12/2016
2	Virilism (Virilization) 01/2019 - 09/2010
2	Fibrous Dysplasia of Bone 08/2007 - 12/2005
1	Hyperprolactinemia 01/2022
1	Prolactinoma (Prolactinomas) 01/2022
1	Achondroplasia 12/2021
1	Delayed Puberty 03/2020
1	Gender Dysphoria 01/2019
1	Feminization 01/2019
1	Congenital Hypothyroidism (Cretinism) 09/2017
1	Hemorrhage 07/2017
1	Diabetes Insipidus 12/2016
1	Familial Testotoxicosis 01/2016
1	Hypogonadism (Hypergonadotropic Hypogonadism) 11/2013
1	Brain Neoplasms (Brain Tumor) 11/2011
1	Wiskott-Aldrich Syndrome 03/2011
1	Confusion (Bewilderment) 03/2011
1	Septo-Optic Dysplasia 06/2010
1	Prostatic Neoplasms (Prostate Cancer) 09/2009
1	Weight Gain 04/2009
1	Gynecomastia 04/2008
1	Leukemia 02/2008
1	Urinary Tract Infections (Urinary Tract Infection) 08/2007
1	Tachypnea 08/2007
1	Laryngomalacia 08/2007
1	Congenital Hyperinsulinism 08/2007
1	Hypoxia (Hypoxemia) 08/2007
1	Apnea 08/2007
1	Pulmonary Hypertension 08/2007
1	Slipped Capital Femoral Epiphyses 12/2006
1	Monosomy 12/2006
1	Hyperphosphatemia 12/2006

Drug/Important Bio-Agent (IBA)

15	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2020 - 05/2007
11	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022 - 05/2007
7	histrelin (Supprelin)FDA Link 01/2016 - 05/2007
6	Growth Hormone (Somatotropin)IBA 01/2021 - 09/2005
4	Estrogens (Estrogen)FDA Link 07/2017 - 01/2004
4	Hormones (Hormone)IBA 11/2011 - 09/2005
4	Insulin (Novolin)FDA Link 05/2009 - 06/2004
3	SteroidsIBA 03/2020 - 01/2009
3	AndrogensIBA 01/2019 - 01/2016
3	GonadotropinsIBA 09/2010 - 01/2004
3	Aromatase InhibitorsIBA 09/2010 - 01/2004
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2016
2	GlucocorticoidsIBA 01/2022 - 01/2016
2	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2020 - 03/2013
2	bicalutamide (Casodex)FDA LinkGeneric 01/2019 - 09/2010
2	4-(fluoromethyl)phenyl phosphate (FMPP)IBA 01/2019 - 01/2016
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2017 - 12/2006
2	LH Receptors (LH Receptor)IBA 01/2016 - 09/2010
2	Thyroid HormonesIBA 03/2009 - 07/2002
2	Thyroid-Stimulating ImmunoglobulinsIBA 11/2008 - 07/2002
2	EnzymesIBA 04/2008 - 07/2004
2	DNA (Deoxyribonucleic Acid)IBA 08/2007 - 01/2002
1	ProlactinIBA 01/2022
1	Cabergoline FDA LinkGeneric 01/2022
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2022
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 12/2021
1	vosoritideIBA 12/2021
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2021
1	Leuprolide (Lupron)FDA LinkGeneric 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2017
1	SodiumIBA 12/2016
1	Prednisone (Sone)FDA LinkGeneric 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Vasopressins (Vasopressin)IBA 01/2015
1	Estrogen Receptor AntagonistsIBA 09/2012
1	Fulvestrant (Faslodex)FDA Link 09/2012
1	Protons (Proton)IBA 11/2011
1	Hemoglobins (Hemoglobin)IBA 04/2011
1	Testosterone (Sustanon)FDA Link 09/2010
1	HydrogelsIBA 09/2009
1	Anastrozole (Arimidex)FDA LinkGeneric 07/2008
1	Aromatase (CYP19)IBA 04/2008
1	Diazoxide (Hyperstat)FDA Link 08/2007
1	Parathyroid Hormone (Parathormone)IBA 12/2006
1	Follicle Stimulating Hormone (Follitropin)FDA Link 12/2006

Therapy/Procedure

17	Therapeutics 01/2022 - 07/2002
3	Glycemic Control 04/2011 - 06/2004
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2017 - 11/2013
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2011 - 02/2008
2	Aftercare (After-Treatment) 09/2010 - 07/2002
1	Castration 01/2019
1	Proton Therapy 11/2011
1	Radiotherapy 11/2011
1	Estrogen Replacement Therapy 06/2009
1	Ovariectomy (Oophorectomy) 09/2007
1	Antibiotic Prophylaxis 08/2007
1	Injections 05/2007